Paxlovid Kit
Product Images NDC 0069-5434

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Paxlovid (NDC 0069-5434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Paxlovid 01)

Chemical structure of the active ingredient nirmatrelvir, part of the Paxlovid kit. The diagram shows molecular bonds, various functional groups including fluorines, and stereochemistry marked with (S) and (R) configurations.*

FDA Label Image

Chemical Structure (Paxlovid 02)

Chemical structure of nirmatrelvir, the active ingredient in Paxlovid, showing its molecular formula with various functional groups including amide and thiazole rings.*

FDA Label Image

Figure 1 (Paxlovid 03)

A horizontal forest plot showing the percentage difference in efficacy between Nirmatrelvir 300 mg plus Ritonavir 100 mg and placebo across various patient categories. The categories include symptom onset duration, age, gender, BMI, diabetes status, hypertension status, baseline SARS-CoV-2 serology status, baseline nasopharyngeal viral RNA levels, and COVID-19 mAb treatment. The plot illustrates confidence intervals for each category's effect size relative to placebo.*

FDA Label Image

Pfizer (Paxlovid 04)

FDA Label Image

Figure A (Paxlovid 05)

Paxlovid kit by Pfizer Laboratories, containing nirmatrelvir tablets (300 mg) and ritonavir tablets (100 mg) co-packaged for oral use. The label provides dosing instructions to take all 3 tablets together twice daily for 5 days and includes a warning not to cover the ALERT box with pharmacy labels.*

FDA Label Image

Paxlovid (Paxlovid 06)

An illustration diagram for Paxlovid showing the three tablets to be taken together: two nirmatrelvir tablets (150 mg each) and one ritonavir tablet (100 mg). This visual explains the co-packaged oral use dosage of 300 mg nirmatrelvir and 100 mg ritonavir under prescription use.*

FDA Label Image

Paxlovid (Paxlovid 07)

Three oral tablets are shown, two pink and one white. One pink tablet is oval and unmarked, the other pink tablet is oval and imprinted with '30' and 'PFE'. The white tablet is oblong and unmarked. The image corresponds to Paxlovid, a human prescription drug kit containing nirmatrelvir and ritonavir tablets, labeled by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Paxlovid (Paxlovid 08)

Paxlovid kit packaging label by Pfizer Laboratories Div Pfizer Inc. It contains nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg) co-packaged for oral use in a dose pack. The label includes dosing instructions to take both tablets together twice daily for 5 days, with a caution to not cover alert box on the pharmacy label and a note not to alter other medicines without consulting a healthcare provider.*

FDA Label Image

Paxlovid (Paxlovid 09)

Paxlovid kit label displaying nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg). The label indicates these two tablets are co-packaged for oral use and should be taken together. The labeler is Pfizer Laboratories Div Pfizer Inc. The packaging includes a pink background and mentions 'Rx only.'*

FDA Label Image

Paxlovid (Paxlovid 10)

Image of two oblong tablets from the Paxlovid kit, a human prescription drug by Pfizer Laboratories Div Pfizer Inc. One tablet is pink with "PFIZER" imprinted, and the other is plain white. These represent the nirmatrelvir and ritonavir components in tablet form.*

FDA Label Image

Pfizer (Paxlovid 11)

FDA Label Image

Principal Display Panel (3 Tablet Blister Pack)

Paxlovid kit label featuring nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg), co-packaged for oral use. The label instructs to take three tablets together, including two nirmatrelvir tablets and one ritonavir tablet. Distributed by Pfizer Labs, Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Paxlovid 300 mg / 100 mg Dose Pack KIT containing nirmatrelvir and ritonavir tablets co-packaged for oral use. The label displays dosing instructions to take 3 tablets from one blister card twice daily for 5 days. The product is labeled by Pfizer Laboratories Div Pfizer Inc with barcodes and storage information included.*

FDA Label Image

Principal Display Panel (3 Tablet Blister Pack)

The label for Paxlovid kit, containing nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg), co-packaged for oral use. It instructs to take three tablets together, consisting of two nirmatrelvir tablets and one ritonavir tablet. Distributor is Pfizer Labs, Div. of Pfizer Inc, NY.*

FDA Label Image

Principal Display Panel (Kit Carton)

Paxlovid 300 mg; 100 mg Dose Pack packaging label for a human prescription drug kit by Pfizer Laboratories Div Pfizer Inc. The label shows Paxlovid co-packaged tablets of nirmatrelvir and ritonavir for oral use, instructions for dosage (three tablets from one blister card twice daily for 5 days), storage conditions, lot information, barcode, and a QR code for additional prescribing information.*

FDA Label Image

Principal Display Panel (3 Tablet Blister Pack)

Label for Paxlovid kit containing nirmatrelvir tablets (150 mg each) and ritonavir tablets (100 mg), co-packaged for oral use. The label instructs to take three tablets together: two nirmatrelvir tablets and one ritonavir tablet. Distributed by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (Kit Carton)

Paxlovid 300 mg / 100 mg Dose Pack kit packaging label for oral use tablets containing nirmatrelvir and ritonavir. The label states co-packaged tablets with dosing instructions to take all 3 tablets from one blister card twice daily for 5 days. The label shows Pfizer Laboratories Div Pfizer Inc as the labeler, includes a barcode, storage and dispensing information, and manufacturing details.*

FDA Label Image

Principal Display Panel (2 Tablet Blister Pack)

Paxlovid kit label showing the co-packaged tablets: nirmatrelvir 150 mg and ritonavir 100 mg. The label instructs to take the two tablets together and lists Pfizer Laboratories Div Pfizer Inc as the labeler. The label is pink with black text and includes a barcode and NDC number 0069-5017-04.*

FDA Label Image

Principal Display Panel (Kit Carton)

Paxlovid 150 mg and 100 mg Dose Pack packaging label, a kit containing nirmatrelvir and ritonavir tablets co-packaged for oral use. The label includes dosing instructions to take both tablets from one blister card together twice daily for 5 days. Labeler is Pfizer Laboratories Div Pfizer Inc. The design features the Paxlovid name prominently with dosage details and storage instructions, along with barcodes and a QR code.*

FDA Label Image

Principal Display Panel (2 Tablet Blister Pack)

Paxlovid kit label showing nirmatrelvir tablets (150 mg) and ritonavir tablets (100 mg) co-packaged for oral use. The label includes dosage strengths, a barcode, lot and expiration fields, and notes that the kit is Rx only, distributed by Pfizer Laboratories Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Paxlovid kit containing nirmatrelvir and ritonavir tablets in a 150 mg/100 mg dose pack. The label features dosage instructions to take both tablets from one blister card twice daily for 5 days. Manufactured by Pfizer Laboratories Div Pfizer Inc, the label includes barcodes, a QR code, and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.